Published online December 1, 2005
PEDIATRICS Vol. 116 No. 6 December 2005, pp. 1287-1291 (doi:10.1542/peds.2004-2718)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yeung, L. F.
Right arrow Articles by Seward, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeung, L. F.
Right arrow Articles by Seward, J. F.
Related Collections
Right arrow Musculoskeletal System
Right arrowRelated AAP Red Book topics:
Measles

A Limited Measles Outbreak in a Highly Vaccinated US Boarding School

Lorraine F. Yeung, MD, MPH*,{ddagger}, Perrianne Lurie, MD, MPH§, Gustavo Dayan, MD||, Eduard Eduardo, MPH, Phyllis H. Britz, RN§, Susan B. Redd||, Mark J. Papania, MD, MPH|| and Jane F. Seward, MBBS, MPH||

* Epidemic Intelligence Service, Epidemiology Program Office
{ddagger} Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities
|| Viral Vaccine-Preventable Diseases Branch, Epidemiology & Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia
§ Pennsylvania Department of Health, Harrisburg, Pennsylvania
Columbia University, New York, New York

Objectives. We investigated a measles outbreak that began in March 2003 in a Pennsylvania boarding school with >600 students to identify all cases, including the source; implement outbreak control measures; and evaluate vaccine effectiveness.

Methods. Measles was suspected in any person at the school with a generalized rash and fever during March 21 to May 28, 2003 and investigated with serologic testing. We reviewed vaccination history from school records and conducted a survey to determine country of measles vaccination. Vaccine effectiveness was calculated using the cohort method.

Results. We identified 9 laboratory-confirmed cases at the school: 8 students and 1 staff member. Among them, 2 had never received any doses of measles-containing vaccine (MCV), 1 received 1 dose of MCV, and 6 received 2 doses of MCV. Three of the 6 who received 2 doses of MCV received both doses outside the United States. The source case had been infected in Lebanon. Two laboratory-confirmed spread cases were identified in New York City. Measles virus of genotype D4 was isolated in cases from the school and New York City. Of the 663 students in the school, 8 (1.2%) had never received any doses of MCV, 26 (3.9%) had received 1 dose, and 629 (94.9%) had received 2 doses before the outbreak. Vaccine effectiveness among students who had received 2 doses of MCV was 98.6%. However, students who received both doses outside the United States had a higher attack rate (3 of 75) than those who received both doses in the United States (3 of 509; rate ratio: 6.8; 95% confidence interval: 1.4–33.0).

Conclusions. This is the largest measles outbreak to occur in a school in the United States since 1998, but it was limited to only 9 cases in a boarding school with >600 students. The limited extent of this outbreak highlights the high level of population immunity achieved in the United States through widespread implementation of a 2-dose measles-mumps-rubella vaccination strategy in school-aged children. States and schools should continue to enforce strictly the 2-dose measles-mumps-rubella vaccination requirement and, in an outbreak setting, consider revaccinating students who received measles vaccine outside of the United States. Continued vigilance by health care providers is needed to recognize measles cases.

Key Words: measles • measles-mumps-rubella vaccine • vaccines • disease outbreaks • immunizations • school • school-aged children

Abbreviations: MCV, measles-containing vaccine • MMR, measles-mumps-rubella • PADOH, Pennsylvania Department of Health • IgM, immunoglobulin M • IgG, immunoglobulin G • VE, vaccine effectiveness • CI, confidence interval

Accepted Mar 1, 2005.




This article has been cited by other articles:


Home page
 PediatricsHome page
D. B. Fishbein, K. R. Broder, L. Markowitz, and N. Messonnier
New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent
Pediatrics, January 1, 2008; 121(Supplement_1): S5 - S14.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. K. Raut, P. S. Kulkarni, M. A. Phadke, S. S. Jadhav, S. V. Kapre, R. M. Dhere, S. P. Dhorje, and S. R. Godse
Persistence of Antibodies Induced by Measles-Mumps-Rubella Vaccine in Children in India
Clin. Vaccine Immunol., October 1, 2007; 14(10): 1370 - 1371.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
C. W. LeBaron, J. Beeler, B. J. Sullivan, B. Forghani, D. Bi, C. Beck, S. Audet, and P. Gargiullo
Persistence of Measles Antibodies After 2 Doses of Measles Vaccine in a Postelimination Environment
Arch Pediatr Adolesc Med, March 1, 2007; 161(3): 294 - 301.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. T. D'Angio, P. A. Boohene, A. Mowrer, S. Audet, M. A. Menegus, D. S. Schmid, and J. A. Beeler
Measles-Mumps-Rubella and Varicella Vaccine Responses in Extremely Preterm Infants
Pediatrics, March 1, 2007; 119(3): e574 - e579.
[Abstract] [Full Text] [PDF]